doxorubicin

简明释义

[ˌdɒksəˈruːbəsɪn][ˌdɑːksəˈruːbɪsɪn]

n. 阿霉素;亚德里亚霉素

英英释义

Doxorubicin is a chemotherapy medication used to treat various types of cancer, including breast cancer, bladder cancer, and leukemia.

多柔比星是一种用于治疗多种癌症的化疗药物,包括乳腺癌、膀胱癌和白血病。

It works by intercalating DNA strands and inhibiting the enzyme topoisomerase II, which helps to prevent cancer cell replication.

它通过插入DNA链并抑制拓扑异构酶II来发挥作用,这有助于防止癌细胞复制。

Doxorubicin can have side effects such as nausea, vomiting, hair loss, and increased risk of infection.

多柔比星可能会有副作用,如恶心、呕吐、脱发和感染风险增加。

单词用法

doxorubicin administration

多柔比星给药

doxorubicin dosage

多柔比星剂量

doxorubicin treatment

多柔比星治疗

doxorubicin-based therapy

基于多柔比星的治疗

doxorubicin resistance

多柔比星耐药

doxorubicin side effects

多柔比星副作用

同义词

Adriamycin

阿霉素

Doxorubicin is commonly used in chemotherapy for various types of cancer.

多柔比星常用于治疗多种类型的癌症化疗中。

DOX

多柔比星

Adriamycin is often administered intravenously to treat breast cancer.

阿霉素通常通过静脉注射用于治疗乳腺癌。

反义词

healthy

健康的

Maintaining a healthy lifestyle can prevent the need for chemotherapy drugs like doxorubicin.

保持健康的生活方式可以避免需要像多柔比星这样的化疗药物。

non-toxic

无毒的

Non-toxic treatments are increasingly being researched as alternatives to traditional chemotherapy.

无毒治疗正在越来越多地被研究作为传统化疗的替代方案。

例句

1.Aim: To study whether doxorubicin could increase the H4 glioma cell death induced by TRAIL and investigate the underlying mechanism.

目的:探讨阿霉素联合TRAIL对人神经胶质瘤h 4细胞增殖的影响。

2.In this study, the researchers attached two drugs - TRAIL and doxorubicin (dox) - onto graphene strips.

在这项研究中,研究人员把两种药物——抗癌蛋白trail和阿霉素(强力霉素)——连接到石墨烯带。

3.Objective: To study on the curative effect of magnetic doxorubicin stealth liposome in human gastric cancer xenografts in nude mice.

目的:研究磁性阿霉素隐形脂质体对裸鼠移植性人胃癌的疗效。

4.Finally, we studied the drug delivery behaviors of the embedding of this anti-cancer drug doxorubicin (dox) micelles in a simulated human body environment.

最后,我们研究了这种胶束包埋抗癌药物阿霉素(DOX)在模拟人体环境中的药物控释行为。

5.Sterile pyrogen-free, orange red, freeze-dried powder in vials containing 10mg and 50mg of doxorubicin hydrochloride with lactose.

(本品)为小瓶装,灭菌无热原,桔红色冻干粉沫,每小瓶含有10mg或50mg阿霉素盐酸盐与乳糖。

6.Conclusion: Magnetic doxorubicin stealth liposome, regarding as a new kind carrier of anti-tumor drug, indicated a favorable foreground.

结论:磁性阿霉素隐形脂质体作为一种新型抗肿瘤药物显示了良好的应用前景。

7.Conclusion: Conclusion: The dysuria and vomiting pill has certain curative effect on doxorubicin-induced renal insufficiency in rats.

结论:关格片对大鼠肾功能不全有一定的治疗作用。

8.Objective to evaluate the significance of flow cytometry (FCM) in the analysis of multi drug resistance of doxorubicin.

目的探讨流式细胞术在阿霉素多药耐药研究中的特殊意义。

9.Conclusion: Doxorubicin phospholipid nanoparticle is able to become a new drug targeting carrier system.

结论:肝癌特异性多柔比星免疫磷脂纳米粒,有可能成为一种新的药物靶向载体系统。

10.The oncologist recommended using doxorubicin for the treatment of breast cancer.

肿瘤科医生建议使用doxorubicin治疗乳腺癌。

11.Patients receiving doxorubicin should be monitored for potential heart problems.

接受doxorubicin治疗的患者应监测潜在的心脏问题。

12.The side effects of doxorubicin can include nausea and hair loss.

使用doxorubicin的副作用可能包括恶心和脱发。

13.Research is being conducted to improve the efficacy of doxorubicin in cancer therapy.

正在进行研究以提高doxorubicin在癌症治疗中的疗效。

14.Combination therapies with doxorubicin have shown promising results in clinical trials.

doxorubicin联合治疗在临床试验中显示出良好的结果。

作文

Doxorubicin, a powerful chemotherapeutic agent, plays a crucial role in the treatment of various cancers. This anthracycline antibiotic, derived from the bacterium Streptomyces peucetius, is widely used to treat conditions such as breast cancer, leukemia, and lymphoma. The mechanism of action of doxorubicin involves intercalating into DNA strands, inhibiting the synthesis of nucleic acids, and ultimately leading to cell death. This unique property makes doxorubicin an effective treatment option, but it also comes with a range of potential side effects that both patients and healthcare providers must consider.One of the most significant advantages of doxorubicin is its efficacy in shrinking tumors and prolonging survival rates in cancer patients. Clinical studies have shown that when used in combination with other chemotherapy agents, doxorubicin can enhance the overall effectiveness of treatment protocols. However, it is essential to monitor patients closely for adverse reactions, as doxorubicin is known to cause cardiotoxicity, which can lead to heart failure if not managed properly.In addition to its therapeutic benefits, the administration of doxorubicin requires careful consideration of dosage and scheduling. Oncologists often tailor treatment plans based on individual patient needs, taking into account factors such as cancer type, stage, and overall health. The typical route of administration for doxorubicin is intravenous, allowing for direct delivery into the bloodstream. Patients may receive this medication in cycles, with periods of rest in between to allow their bodies to recover from the intense effects of chemotherapy.Moreover, the discovery of doxorubicin has paved the way for further research into cancer treatments. Scientists are continually exploring ways to enhance its efficacy and reduce side effects, leading to the development of liposomal formulations that encapsulate doxorubicin and target cancer cells more precisely. These advancements hold promise for improving patient outcomes and minimizing the collateral damage often associated with traditional chemotherapy.Despite its challenges, the role of doxorubicin in oncology cannot be overstated. It remains a cornerstone of cancer treatment regimens and has been instrumental in saving countless lives. As research continues to unveil new insights into its mechanisms and applications, doxorubicin will likely maintain its status as a vital tool in the fight against cancer. For patients diagnosed with malignancies, understanding the significance of doxorubicin can empower them to engage in informed discussions with their healthcare teams, fostering a collaborative approach to their treatment journey. In conclusion, while doxorubicin poses certain risks, its benefits in treating life-threatening cancers make it an indispensable part of modern oncology.

doxorubicin是一种强效的化疗药物,在各种癌症的治疗中发挥着至关重要的作用。这种来源于放线菌Streptomyces peucetius的蒽环类抗生素,广泛用于治疗乳腺癌、白血病和淋巴瘤等疾病。doxorubicin的作用机制涉及插入DNA链中,抑制核酸的合成,并最终导致细胞死亡。这一独特的特性使得doxorubicin成为一种有效的治疗选择,但它也伴随着一系列潜在的副作用,患者和医疗提供者必须认真考虑。doxorubicin最显著的优点之一是其在缩小肿瘤和延长癌症患者生存率方面的有效性。临床研究表明,当与其他化疗药物联合使用时,doxorubicin可以增强治疗方案的整体效果。然而,必须密切监测患者的不良反应,因为doxorubicin已知会引起心脏毒性,如果管理不当,可能导致心力衰竭。除了治疗益处外,doxorubicin的给药也需要仔细考虑剂量和时间安排。肿瘤科医生通常会根据个体患者的需求量身定制治疗计划,考虑到癌症类型、阶段和整体健康状况等因素。doxorubicin的典型给药途径是静脉注射,允许直接输送到血液中。患者可能会以周期性方式接受这种药物,期间有休息时间,以便让他们的身体从强烈的化疗效果中恢复。此外,doxorubicin的发现为进一步研究癌症治疗铺平了道路。科学家们不断探索增强其疗效和减少副作用的方法,从而开发出能够包裹doxorubicin并更精确地靶向癌细胞的脂质体制剂。这些进展为改善患者预后和最小化传统化疗常伴随的附带损伤带来了希望。尽管面临挑战,doxorubicin在肿瘤学中的作用不可低估。它仍然是癌症治疗方案的基石,并在拯救无数生命方面发挥了重要作用。随着研究不断揭示其机制和应用的新见解,doxorubicin可能会继续作为对抗癌症的重要工具。对于被诊断为恶性肿瘤的患者来说,了解doxorubicin的重要性可以使他们能够与医疗团队进行知情讨论,从而促进他们治疗旅程的协作方式。总之,虽然doxorubicin存在某些风险,但其在治疗危及生命的癌症方面的益处使其成为现代肿瘤学不可或缺的一部分。